Photo Gallery

Login

Search

News & Updation

  • Updated Version
  • WJPPS introducing updated version of OSTS (online submission and tracking system), which have dedicated control panel for both author and reviewer. Using this control panel author can submit manuscript
  • Call for Paper
    • WJPPS  Invited to submit your valuable manuscripts for Coming Issue.
  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.
  •  
  • WJPPS Impact Factor
  • Its our Pleasure to Inform you that WJPPS Impact Factor has been increased from  7.454 to 7.632  due to high quality Publication at International Level

  • ICV
  • WJPPS Rank with Index Copernicus Value 84.65 due to high reputation at International Level

  • WJPPS OCTOBER ISSUE PUBLISHED
  • OCTOBER 2020 Issue has been successfully launched on 1 October 2020.

Abstract

ROLE OF REGULATORY AFFAIRS IN THE BRICS COUNTRIES

Dakme Papi, Biplab Kr. Dey and Ruhul Amin*

ABSTRACT

BRICS essentially incorporate the developing markets of India, Russia, Brazil, China, and South Africa. The development of the pharmaceutical market in these nations has been expanding the most recent two decades. The growth of the pharmaceutical market relies on the medication administrative framework and administrative medication laws. In the pharmaceutical industry, regulatory affairs play an essential role as the pharmaceutical sector is increasing very rapidly. An organizational undertaking is a calling that goes about as the interface between pharmaceutical business and government specialists over the World. The drive behind the present examination is to analyze existing ERA methodology for human pharmaceuticals and to feature their qualities and limitations. Existing ERA frameworks for human medicines have assumed critical jobs in improving ecological attention to the pharmaceutical businesses and in ensuring natural well being. This article summarizes the various aspect of regulatory affairs in BRICS country and it also gives an insight into the new drug development process and a regulatory guideline of entry of new molecule in BRICS country.

Keywords: BRICS country, Generic drug registration, Medical devices, Regulation.


[Full Text Article]

Call for Paper

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Online Submission

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Email & SMS Alert

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More